[SLRX] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
23-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 28.35%
YoY- 6.27%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 -1,840 1,479 1,039 163 283 299 -
PBT -6,371 -4,105 -1,768 -1,882 -2,009 -8,029 -7,900 -3.52%
Tax 111 -44 10 1 -51 -74 -112 -
NP -6,482 -4,105 -1,768 -1,883 -2,009 -8,029 -7,900 -3.24%
Tax Rate - - - - - - - -
Total Cost 6,482 2,265 3,246 2,922 2,172 8,312 8,199 -3.83%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 223.06 -119.52 -181.27 -1,232.52 -2,837.10 -2,642.14 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.88 -2.27 -2.84 -14.40 -69.50 -284.43 -297.08 -53.80%
EPS Diluted -2.88 -2.27 -2.84 -14.40 -69.50 -284.43 -297.08 -53.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.